Scientific LetterIsoniazid-Resistant Rifampicin-Susceptible Tuberculosis in ChildrenTuberculosis resistente a isoniacida y sensible a rifampicina en niños☆
References (15)
- et al.
Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis
Lancet Infect Dis
(2017) - et al.
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis
Lancet Respir Med
(2018) Global tuberculosis report 2017
(2017)- et al.
Isoniazid-resistant tuberculosis in children: a systematic review
Pediatr Infect Dis J
(2013) - et al.
Quantifying the burden and trends of isoniazid resistant tuberculosis, 1994–2009
PLoS One
(2011) - et al.
Global and regional burden of isoniazid-resistant tuberculosis
Pediatrics
(2015) Informe epidemiológico sobre la situación de la tuberculosis en España. Año 2014
(2015)
There are more references available in the full text version of this article.
Cited by (0)
- ☆
Please cite this article as: Morales Pérez C, Gomez-Pastrana D, Aragón Fernández C, Pérez Escolano E. Tuberculosis resistente a isoniacida y sensible a rifampicina en niños. Arch Bronconeumol. 2019;55:388–390.
© 2018 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.